Core Insights - Cirrus Logic, Inc. reported better-than-expected earnings for the second quarter, with earnings of $2.83 per share, surpassing the analyst consensus estimate of $2.37 per share [1] - The company achieved quarterly sales of $560.960 million, exceeding the analyst consensus estimate of $540.385 million [1] - For the third quarter, Cirrus Logic anticipates sales between $500.000 million and $560.000 million, compared to estimates of $508.763 million [1] Company Performance - The September quarter saw record revenue driven by strong demand for components used in smartphones, as stated by the CEO John Forsyth [2] - Following the earnings announcement, Cirrus Logic shares fell by 1.2%, closing at $129.63 [2] Analyst Ratings - Keybanc analyst John Vinh maintained an Overweight rating on Cirrus Logic and raised the price target from $135 to $150 [4] - Stifel analyst Tore Svanberg also maintained a Buy rating and increased the price target from $140 to $150 [4]

Earnings Report - AppLovin Corporation is set to release its third-quarter earnings results on November 5, with analysts expecting earnings of $2.39 per share, an increase from $1.25 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.34 billion, compared to $1.2 billion a year earlier [1] Stock Performance - AppLovin shares experienced a decline of 3.7%, closing at $608.68 [2] Analyst Ratings - BTIG analyst Clark Lampen maintained a Buy rating and raised the price target from $664 to $693 [4] - Wedbush analyst Alicia Brondolo maintained an Outperform rating and increased the price target from $725 to $745 [4] - Citigroup analyst Jason Bazinet maintained a Buy rating and raised the price target from $600 to $850 [4] - B of A Securities analyst Omar Dessouky maintained a Buy rating and increased the price target from $580 to $860 [4] - Morgan Stanley analyst Matthew Cost maintained an Overweight rating and raised the price target from $480 to $750 [4]

Earnings Results - Johnson Controls International plc is set to release its fourth-quarter earnings results on November 5, with analysts expecting earnings of $1.20 per share, a decrease from $1.28 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $6.33 billion, down from $7.39 billion a year earlier [1] Recent Developments - On September 24, Johnson Controls announced the appointment of Todd Grabowski as vice president and president for the Americas [2] - The company's shares fell by 1.9%, closing at $111.04 on Tuesday [2] Analyst Ratings - JP Morgan analyst Stephen Tusa maintained an Overweight rating and raised the price target from $105 to $125 [4] - Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and increased the price target from $112 to $119 [4] - Morgan Stanley analyst Chris Snyder maintained an Overweight rating and raised the price target from $115 to $125 [4] - RBC Capital analyst Deane Dray maintained a Sector Perform rating and increased the price target from $112 to $114 [4] - Barclays analyst Julian Mitchell maintained an Equal-Weight rating and raised the price target from $100 to $101 [4]

Group 1 - Super Micro Computer, Inc. is set to release its first-quarter earnings results on November 4, with expected earnings of 39 cents per share, a decrease from 74 cents per share in the same period last year [1] - The consensus estimate for Super Micro Computer's quarterly revenue is $5.8 billion, down from $5.94 billion a year earlier [1] - On October 29, Super Micro Computer announced the formation of a federal subsidiary, Super Micro Federal LLC, aimed at accelerating its expansion into the federal market [2] Group 2 - Super Micro Computer shares experienced a decline of 2.3%, closing at $50.75 on the preceding Monday [2] - Goldman Sachs analyst Michael Ng maintained a Sell rating with a price target increase from $27 to $30 [5] - JP Morgan analyst Samik Chatterjee maintained a Neutral rating and reduced the price target from $45 to $43 [5] - Rosenblatt analyst Kevin Cassidy maintained a Buy rating and raised the price target from $50 to $60 [5] - Bernstein analyst Mark Newman initiated coverage with a Market Perform rating and a price target of $46 [5] - Barclays analyst Tim Long maintained an Equal-Weight rating and increased the price target from $29 to $45 [5]

Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4.Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in the year-ago period. The consensus estimate for Pfizer’s quarterly revenue is $16.52 billion, down from $17.7 billion a year earlier, according to Benzinga Pro.On Friday, Pfizer filed a lawsuit against Metsera, Inc. (NASDAQ:MTSR), its Board of Directors, and Novo Nordisk ( ...

Lear Corporation (NYSE:LEA) reported upbeat earnings for the third quarter on Friday.The company posted quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.73 per share. The company reported quarterly sales of $5.680 billion which beat the analyst consensus estimate of $5.600 billion.Lear raised its FY2025 sales guidance from $22.470 billion-$23.070 billion to $22.850 billion-$23.150 billion.“Lear continued its solid momentum in the third quarter, delivering one of the high ...

Core Insights - Lear Corporation reported strong earnings for Q3, with earnings per share of $2.79, surpassing the analyst consensus estimate of $2.73 [1] - The company achieved quarterly sales of $5.680 billion, exceeding the analyst consensus estimate of $5.600 billion [1] - Lear raised its FY2025 sales guidance to a range of $22.850 billion to $23.150 billion, up from the previous guidance of $22.470 billion to $23.070 billion [1] Financial Performance - The company experienced one of its highest third-quarter operating cash flows in history, indicating solid operational performance across both business segments [2] - Despite facing disruptions at key customers, Lear maintained strong operational performance [2] Stock Market Reaction - Following the earnings announcement, Lear's shares increased by 3.7%, trading at $108.55 [2] Analyst Ratings and Price Targets - Wells Fargo analyst Colin Langan maintained an Equal-Weight rating and raised the price target from $108 to $112 [4] - JP Morgan analyst Ryan Brinkman maintained an Overweight rating and increased the price target from $133 to $138 [4] - TD Cowen analyst Itay Michaeli maintained a Hold rating and raised the price target from $115 to $117 [4]

Core Insights - nVent Electric plc reported third-quarter results that exceeded street estimates, with adjusted earnings of 91 cents per share, a 44% increase year-over-year, surpassing expectations of 88 cents [1] - Net sales reached $1.05 billion, a 35% increase from the previous year, exceeding estimates of $1.01 billion, while organic sales growth was 16% for the quarter [1] - Adjusted operating income rose 27% to $213 million [1] Full-Year Outlook - nVent Electric raised its full-year 2025 sales growth outlook to 27% to 28%, up from the previous guidance of 24% to 26% [2] - The company projects adjusted earnings per share of $3.31 to $3.33, compared to the earlier range of $3.22 to $3.30 [2] - Wall Street analysts expect earnings of $3.29 per share from sales of $3.76 billion [2] Fourth Quarter Projections - For the fourth quarter, nVent anticipates reported sales growth of 31% to 33% and organic sales growth of 15% to 17% [3] - The adjusted EPS forecast for the fourth quarter is between 87 cents and 89 cents, while analysts expect an adjusted EPS of 88 cents [3] - Following the earnings announcement, nVent Electric shares fell 1% to trade at $113.22 [3] Analyst Ratings and Price Targets - RBC Capital analyst Deane Dray maintained an Outperform rating and raised the price target from $117 to $133 [5] - Goldman Sachs analyst Joe Ritchie maintained a Buy rating and raised the price target from $111 to $140 [5] - Roth Capital analyst Justin Clare reiterated a Buy rating and raised the price target from $115 to $130 [5]

Core Insights - Vertex Pharmaceuticals is set to release its Q1 earnings results on November 3, with expected earnings of $4.58 per share, an increase from $4.38 per share in the same quarter last year [1] - The anticipated quarterly revenue for Vertex is $3.06 billion, up from $2.77 billion year-over-year [1] Analyst Ratings - Morgan Stanley's Terence Flynn maintains an Equal-Weight rating, lowering the price target from $439 to $438 [4] - JP Morgan's Jessica Fye keeps an Overweight rating, raising the price target from $517 to $530 [4] - Citigroup's Geoff Meacham maintains a Buy rating, increasing the price target from $550 to $575 [4] - Leerink Partners' David Risinger upgraded the stock from Market Perform to Outperform, adjusting the price target from $458 to $456 [4] - Evercore ISI Group's Lisa Bayko maintains an Outperform rating, reducing the price target from $510 to $475 [4]

Core Insights - Vertex Pharmaceuticals is set to release its Q1 earnings results on November 3, with expected earnings of $4.58 per share, an increase from $4.38 per share in the same quarter last year [1] - The anticipated quarterly revenue for Vertex is $3.06 billion, up from $2.77 billion year-over-year [1] Analyst Ratings - Morgan Stanley's Terence Flynn maintains an Equal-Weight rating, lowering the price target from $439 to $438 [4] - JP Morgan's Jessica Fye keeps an Overweight rating, raising the price target from $517 to $530 [4] - Citigroup's Geoff Meacham maintains a Buy rating, increasing the price target from $550 to $575 [4] - Leerink Partners' David Risinger upgraded the stock from Market Perform to Outperform, adjusting the price target from $458 to $456 [4] - Evercore ISI Group's Lisa Bayko maintains an Outperform rating, reducing the price target from $510 to $475 [4]